Neurological expertise is essential for Zika virus infection

The Lancet Neurology

Volumn 15, Issue 4, 2016, Pages 353-354

  Shakir, Raad ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

GUILLAIN BARRE SYNDROME; HUMAN; LETTER; MICROCEPHALY; PLASMAPHERESIS; PRIORITY JOURNAL; VIRUS INFECTION; ZIKA VIRUS INFECTION; COMMUNICABLE DISEASES, EMERGING; FEMALE; PANDEMIC; PATHOGENICITY; PREGNANCY; ZIKA FEVER; ZIKA VIRUS;

COMMUNICABLE DISEASES, EMERGING; FEMALE; HUMANS; PANDEMICS; PREGNANCY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84960492440     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(16)00072-7     Document Type: Letter

References (7)

1. Zika virus: a new global threat for 2016. Lancet 2016, 387:96. The Lancet.
2. Mlakar J, Korva M, Tul N, et al. Zika virus associated microcephaly. N Eng J Med 2016, published online Feb 10. 10.1056/NEJMoa1600651.
3. Hughes RAC, Wijdicks EFM, Barohn R, et al. Practice parameters: immunotherapy for Guillain-Barré syndrome. Report of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology 2003, 61:736-740.
4. Hughes RAC, Wijdicks EFM, Benson E, et al. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol 2005, 62:1194-1198.
5. Pritchard J What's new in Guillain-Barré syndrome. Postgrad Med J 2008, 84:532-538.
6. Clinical Guidelines for Immunoglobulin use 2011, UK Department of Health, UK Department of Health, London. 2nd edn update.
7. van den Berg B, Waalgard C, Drenthen J, Fokke C, Jocobs BC, van Doorn PA Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014, 10:469-482.